| Jennifer Clare Jones | |
| Workplaces: | National Cancer Institute |
| Fields: | Radiation oncology, translational nanobiology |
| Doctoral Advisor: | Dale Umetsu |
| Thesis Title: | Identification of Tapr, a T cell and airway phenotype regulatory locus, and positional cloning of the Tim gene family |
| Thesis Year: | 2001 |
| Thesis Url: | https://www.worldcat.org/oclc/245537990 |
| Other Names: | Jennifer Jones McIntire |
Jennifer Clare Jones is an American radiation oncologist and biologist. She is an investigator and head of the translational nanobiology section at the National Cancer Institute.
Jones completed a M.D. and Ph.D. from Stanford University. She is a board-certified radiation oncologist specialized training in radiosurgery, with graduate and postdoctoral training in both cancer biology and general immunology.[1] Her doctoral advisor was . Jones' dissertation in 2001 was titled, Identification of Tapr, a T cell and airway phenotype regulatory locus, and positional cloning of the Tim gene family.[2]
Jones is a NIH Stadtman Investigator and head of the translational nanobiology section at the National Cancer Institute.[3]
From 2001 to 2003, Jones positionally cloned the T-cell immunoglobulin mucin (TIM) gene family and demonstrated the genetic association between TIMs and immune response profiles. As a radiation oncologist, her research is focused on developing immune-based therapies that synergize with radiation to produce optimal anti-tumor immune responses. Jones develops improved methods to characterize, sort, and perform functional studies of nanoparticles, and has established a translational EV analysis pipeline, with instrumentation for preparation, analysis, counting, and cytometric study of extracellular vesicles.